Back to results
US 12,723,064 B2Granted
Treating Alzheimer's disease
AssigneesYeda Research and Development Co. Ltd., Ramot at Tel-Aviv University Ltd.
InventorsRuth Arnon, Ruth Maron, Gad Armony, Michael Menachem Tsoory, Meir Wilchek, Dan Frenkel
Life of this patent
Estimating the term…
Abstract
A method of treating Alzheimer's Disease (AD) is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which prevents the binding of amyloid precursor protein (APP) to Tau protein.
Claims8
A method of alleviating symptoms of Alzheimer's Disease (AD) in a subject in need thereof comprising administering to the subject a therapeutically effective amount of at least one peptide comprising both the amino acid sequence as set forth in SEQ ID NO:
- 1 and the amino acid sequence as set forth in SEQ ID NO:
- 3, which prevents the binding of amyloid precursor protein (APP) to Tau protein, thereby treating the AD.
Dependencies are inferred from the claim text.